Ginkgo biloba doesn’t prevent Alzheimer’s

January, 2013

The second large-scale study investigating whether gingko biloba helps prevent Alzheimer’s has confirmed that it doesn’t.

Sad to say, another large study has given the thumbs down to ginkgo biloba preventing Alzheimer’s disease.

The randomized, double-blind trial took place over five years, involving 2854 older adults (70+) who had presented to their primary care physician with memory complaints. Half were given a twice-daily dose of 120 mg standardised ginkgo biloba extract and half a placebo.

After five years, 4% of those receiving ginkgo biloba had been diagnosed with probable Alzheimer's disease, compared with 5% in the placebo group — an insignificant difference. There was no significant difference between the groups in mortality, stroke, or cardiovascular events, either.

The French study confirms the findings of an earlier American trial, and is also consistent with another large, long-running study that found no benefits of ginkgo biloba for age-related cognitive decline.

http://www.eurekalert.org/pub_releases/2012-09/l-gbe090412.php

Reference: 

[3240] Vellas, B., Coley N., Ousset P-J., Berrut G., Dartigues J-F., Dubois B., et al.
(2012).  Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.
The Lancet Neurology. 11(10), 851 - 859.

Related News

Unmet needs among those living at home with dementia

A study involving 254 people with dementia living at home has found that 99% of people with dementia and 97% of their caregivers had one or more unmet needs, 90% of which were safety-related.
Alzheimer's a much larger cause of death than reported

A new U.S. study suggests that Alzheimer's disease and other dementias are markedly under-reported on death certificates and medical records. Death certificates tend to only provide an immediate cause, such as pneumonia, and don’t mention the underlying condition that provoked it.
Highest risk Alzheimer's genetic carriers take positive steps after learning risk status

It’s often argued that telling people that they carry genes increasing their risk of Alzheimer’s will simply upset them to no purpose. A new study challenges that idea.
Genes implicated in late-onset Alzheimer's disease

11 new genetic susceptibility factors for Alzheimer’s identified
Genes involved in familial Alzheimer's disease

Understanding a protein's role in familial Alzheimer's disease
Gene variation associated with brain atrophy in MCI

Analysis of data from 237 patients with mild cognitive impairment (mean age 79.9) has found that, compared to those carrying the ‘normal’ ApoE3 gene (the most common variant of the ApoE gene), the ApoE4 carriers showed markedly greater rates of shrinkage in 13 of 15 brain regions thought to be k
Alzheimer's gene worse for women

Analysis of data from more than 8,000 people, most of them older than 60, has revealed that, among the 5,000 people initially tested cognitively normal, carrying one copy of the “Alzheimer’s gene” (ApoE4) only slightly increased men’s risk of developing

Gene variant makes some brains more resilient to Alzheimer's

Analysis of 700 subjects from the Alzheimer's Disease Neuroimaging Initiative has revealed a genetic mutation (rs4728029) that’s associated with people who develop Alzheimer’s pathology but don’t show clinical symptoms in their lifetime.
Site of plaque buildup matters

Analysis of brain scans and cognitive scores of 64 older adults from the NIA's Baltimore Longitudinal Study of Aging (average age 76) has found that, between the most cognitively stable and the most declining (over a 12-year period), there was no significant difference in the total amount of amy
Loss of smell early sign of Alzheimer’s

A pilot study involving 94 older adults, of whom 18 had Alzheimer’s, 24 had

Pages

more
Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news